Transplantation for MDS in the elderly: more evidence, or more bias?

Affiliations

Free article

Comment

Corey Cutler. Biol Blood Marrow Transplant. 2012 Sep.

Free article

. 2012 Sep;18(9):1320-1.

doi: 10.1016/j.bbmt.2012.06.009. Epub 2012 Jun 29.

¹ Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA. Corey_Cutler@dfci.harvard.edu

No abstract available

Comment on

Allogeneic hematopoietic cell transplantation in patients age 60-70 years with de novo high-risk myelodysplastic syndrome or secondary acute myelogenous leukemia: comparison with patients lacking donors who received azacitidine.
Platzbecker U, Schetelig J, Finke J, Trenschel R, Scott BL, Kobbe G, Schaefer-Eckart K, Bornhäuser M, Itzykson R, Germing U, Beelen D, Ehninger G, Fenaux P, Deeg HJ, Adès L; German MDS Study; Cooperative Transplant Study Group; Fred Hutchinson Cancer Research Center; Groupe Francophone des Myelodysplasies. Platzbecker U, et al. Biol Blood Marrow Transplant. 2012 Sep;18(9):1415-21. doi: 10.1016/j.bbmt.2012.05.003. Epub 2012 May 11. Biol Blood Marrow Transplant. 2012. PMID: 22579634 Free PMC article.